It is a pharma private limited company based in Bhiwandi, Maharashtra, India, established in 2012.
2012 | Bhiwandi, Maharashtra, India | ActiveExpel Pharma Private Limited, a active private limited company, was established on 28 August 2012 in Bhiwandi, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51101MH2012PTC235042. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jyoshna Arvind Poola (Director), Arvind Shankar Poola (Director). Past directors included Vishnu Yadagiri Sabbani, Shridhar Venkatesh Donta, Ravi Bhagwan Raccha. Its latest AGM occurred on 11 October 2021, with the balance sheet filed on 31 March 2021. It is based at H. No. 94/1, Gala No. 10/7, B Wing, Saileela Apartment, Telipada, Dhamankar, Naka,, Bhiwandi, Maharashtra, 421302.
U51101MH2012PTC235042
235042
28 August 2012
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Expel Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoshna Arvind Poola | Director | 20 Feb 2021 | Current |
| Arvind Shankar Poola | Director | 28 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 20 Feb 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
| Pramod Abcsdd | Director | 26 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Expel Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 30.58% decrease. The company also saw a substantial improvement in profitability, with a 152.08% increase in profit. The company's net worth Soared by an impressive increase of 48.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Expel Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Expel Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Expel Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Expel Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Expel Pharma Private Limited last Annual general meeting of members was held on 11 Oct 2021 as per latest MCA records. was documented.
Progress on Expel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.
Jyoshna Arvind Poola was appointed as a Director was appointed as a Director on 20 Feb 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
Arvind Shankar Poola was appointed as a Director was appointed as a Director on 28 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Progress on Expel Pharma Private Limited was registered on 28 Aug 2012 with Roc Mumbai & aged 13 years 3 months as per MCA records. was documented.
The CIN of Expel Pharma Private Limited is U51101MH2012PTC235042.
Expel Pharma Private Limited is headquartered at H. No. 94/1, Gala No. 10/7, B Wing, Saileela Apartment, Telipada, Dhamankar, Naka,, Bhiwandi, Maharashtra, 421302.
Expel Pharma Private Limited was incorporated on 28 August 2012.
The current directors of Expel Pharma Private Limited are
The primary industry of Expel Pharma Private Limited is Trade.
Expel Pharma Private Limited is unlisted.
The authorized capital of Expel Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Expel Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX